Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5-HT2 receptors

MDL 11,939 (α‐phenyl‐1‐(2‐phenylethyl)‐4‐piperidine methanol) has been shown, through in vitro studies utilizing radioligand binding and isolated tissues as well as through in vivo tests of central and peripheral serotonergic activity, to be a potent, selective antagonist at 5‐hydroxytryptamine rece...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug development research 1988, Vol.13 (1), p.29-43
Hauptverfasser:	Dudley, Mark W., Wiech, Norbert L., Miller, Francis P., Carr, Albert A., Cheng, Hsien C., Roebel, Lawrence E., Doherty, Niall S., Yamamura, Henry I., Ursillo, Richard C., Palfreyman, Michael G.
Format:	Artikel
Sprache:	eng
Schlagworte:	anti-anxiety anti-inflammatory Biological and medical sciences Medical sciences Muscle Pharmacology. Drug treatments platelet aggregation serotonin antagonist
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!